AIDS
-
Cabotegravir: WHO Recommends Injectable Drug for HIV Prevention for the First Time
The injectable drug is still limited but the WHO recommendation urges countries to deliver cabotegravir for HIV prevention.
Latest Research Articles
-
AIDS Treatment: Scientists Develop Potential 'One Time Treatment' or Vaccine for HIV and AIDS
-
HIV Remains in the Human Tissue Forever Even After Antiretroviral Therapy
-
Emerging Variant of HIV Circulating in Netherlands is Highly-Virulent
-
NY Gov. Cuomo Confident to End AIDS Epidemic by 2020
-
It's National HIV Testing Day: Here's Why You Should Get Checked For It
-
HIV Patient Awarded $18.4 Million In Medical Malpractice Lawsuit
-
Smokers with HIV Infection More Likely to Die From Their Tobacco Use
-
AIDS Breakthrough: How CRISPR Gene Editing Successfully Eliminated HIV Infection in Animal Models
-
Scientists Eliminate HIV in Live Animals for the First Time Using CRISPR Gene Editing Technique
-
'Stealthing': Could This Controversial New Sex Trend Be Considered Rape?
-
SpaceX Tests Superbug in Space, Explores Potential to Become Extinction-Causing Supervirus
-
AIDS Cure? Trials Show Vaccine Therapy Works For a Handful of Patients
most popular
-
World’s Largest Organism May Have Persisted Since the First Human Migrations
-
World’s Biggest Coral, Hidden Beneath Solomon Islands Waters, Revealed by Diver
-
Monkeypox Evolution Reaches Deadly Strain, Now Detected in US
-
Mauna Loa’s Lava Study Confirms Geologists’ Early Warning of Eruption
-
Global Plastic Pileup Could Be Halted With Four Policies, California Study Finds
